Eleftheriadou Aikaterini, Collins Charlotte, Kannapiran Dilaaniy, Antara Faria, Elhammadi Moustafa, Janardanan Sarosh, Mikail Michael, Arumainayagam Nimalan, Carbin Danny Darlington
Department of Urology, Ashford and St Peter's Hospitals, NHS Foundation Trust, Chertsey, Surrey, United Kingdom.
Indian J Urol. 2025 Jul-Sep;41(3):183-189. doi: 10.4103/iju.iju_423_24. Epub 2025 Jul 1.
Transperineal access systems are commonly used to stabilize the biopsy needle with the ultrasound probe in local anesthetic transperineal biopsies (LATPs). However, these devices are expensive and nonreusable and restrict the access to some of the prostatic zones causing excessive probe movement and procedural pain. We aim to assess the pain tolerability, diagnostic value, and safety of the totally freehand LATP (tF-LATP) technique.
Patients undergoing tF-LATP for suspected prostate cancer (PCa) from February 2024 to June 2024 were prospectively included. Data on the prostate-specific antigen (PSA) levels, prostate size, prostate multiparametric magnetic resonance imaging findings, cancer detection, need for immediate rebiopsy due to undersampling (with predefined criteria for immediate rebiopsy), tolerability, and complications were collected. Pain levels were assessed using the Visual Analog Scale (VAS) scores (scores 1-10) at rectal probe insertion and immediately postbiopsy.
Seventy-five patients ( = 75) underwent tF-LATP, with a median age of 67 years. The median PSA level was 7.05 ng/mL, and the median prostate size was 55 cc. During the procedure, the VAS ranged from 1 to 4 (median: 2). Postprocedure the VAS scores ranged from 1 to 2 (median: 1). Forty-four patients (59%) tested positive for PCa. There were no instances of urinary retention, sepsis, or hematuria requiring admission, and none required immediate rebiopsy due to undersampling as per the predefined rebiopsy criteria.
The tF-LATP technique demonstrateed excellent safety, diagnostic efficacy, and satisfactory tolerability. With its cost-effectiveness and enhanced accessibility to all the prostatic lobes, clinicians are encouraged to integrate this technique more widely into clinical practice to maximize its advantages.
在局部麻醉经会阴活检(LATP)中,经会阴接入系统通常用于将活检针与超声探头固定在一起。然而,这些设备价格昂贵且不可重复使用,并且限制了对前列腺某些区域的接入,导致探头过度移动和操作疼痛。我们旨在评估完全徒手LATP(tF-LATP)技术的疼痛耐受性、诊断价值和安全性。
前瞻性纳入2024年2月至2024年6月因疑似前列腺癌(PCa)接受tF-LATP的患者。收集有关前列腺特异性抗原(PSA)水平、前列腺大小、前列腺多参数磁共振成像结果、癌症检测、因采样不足(根据预定义的立即重新活检标准)而需要立即重新活检、耐受性和并发症的数据。在直肠探头插入时和活检后立即使用视觉模拟量表(VAS)评分(1-10分)评估疼痛程度。
75例患者接受了tF-LATP,中位年龄为67岁。中位PSA水平为7.05 ng/mL,中位前列腺大小为55 cc。在手术过程中,VAS评分为1至4分(中位数:2分)。术后VAS评分范围为1至2分(中位数:1分)。44例患者(59%)PCa检测呈阳性。没有发生需要住院治疗的尿潴留、败血症或血尿病例,也没有患者因采样不足根据预定义的重新活检标准需要立即重新活检。
tF-LATP技术显示出出色的安全性、诊断疗效和令人满意的耐受性。鉴于其成本效益和对所有前列腺叶的更高可及性,鼓励临床医生更广泛地将该技术纳入临床实践,以最大限度地发挥其优势。